Ramos-Muntada, M, Trincado, JL, Blanco, J, Bueno, C, Rodriguez-Cortez, VC, Bataller, A, Lopez-Millan, B, Schwab, C, Ortega, M, Velasco, P, Blanco, ML, Nomdedeu, J, Ramirez-Orellana, M, Minguela, A, Fuster, JL, Cuatrecasas, E, Camos, M, Ballerini, P, Escherich, G, Boer, J, DenBoer, M, Hernandez-Rivas, JM, Calasanz, MJ, Cazzaniga, G, Harrison, CJ, Menendez, P, Molina, O. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia. Molecular Oncology. 2022; 16(16)DOI:10.1002/1878-0261.13276. PMID:35726693. IF:6.600(Q1/3D).

Alvarez-Larran, A, Garrote, M, Ferrer-Marin, F, Perez-Encinas, M, Mata-Vazquez, MI, Bellosillo, B, Arellano-Rodrigo, E, Gomez, M, Garcia, R, Garcia-Gutierrez, V, Gasior, M, Cuevas, B, Angona, A, Gomez-Casares, MT, Martinez, CM, Magro, E, Ayala, R, del Orbe-Barreto, R, Perez-Lopez, R, Fox, ML, Raya, JM, Guerrero, L, Garcia-Hernandez, C, Caballero, G, Murillo, I, Xicoy, B, Ramirez, MJ, Carreno-Tarragona, G, Hernandez-Boluda, JC, Pereira, A. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. CANCER. 2022; 128(13)DOI:10.1002/cncr.34195. PMID:35417564. IF:6.200(Q1/3D).

Dunn, WG, Gu, MXS, Fabre, MA, Cooper, J, Nomdedeu, JF, Koumas, L, Nicolaou, K, Chi, JX, Costeas, P, Vassiliou, GS. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients. ANNALS OF HEMATOLOGY. 2022; 101(2)DOI:10.1007/s00277-021-04472-5. PMID:33650061. IF:3.500(Q2/5D).

de la Guardia, RD, Velasco-Hernandez, T, Gutierrez-Aguera, F, Roca-Ho, H, Molina, O, Nombela-Arrieta, C, Bataller, A, Fuster, JL, Anguita, E, Vives, S, Zamora, L, Nomdedeu, J, Gomez-Casares, MT, Ramirez-Orellana, M, Lapillonne, H, Ramos-Mejia, V, Rodriguez-Manzaneque, JC, Bueno, C, Lopez-Millan, B, Menendez, P. Engraftment characterization of risk-stratified AML in NSGS mice. Blood Advances. 2021; 5(23)DOI:10.1182/bloodadvances.2020003958. PMID:34470043. IF:7.642(Q1/3D).

Pich, O, Cortes-Bullich, A, Muinos, F, Pratcorona, M, Gonzalez-Perez, A, Lopez-Bigas, N. The evolution of hematopoietic cells under cancer therapy. Nature Communications. 2021; 12(1)DOI:10.1038/s41467-021-24858-3. PMID:34376657. IF:17.694(Q1/1D).

Martin, I, Villamon, E, Abellan, R, Calasanz, MJ, Irigoyen, A, Sanz, G, Such, E, Mora, E, Gutierrez, M, Collado, R, Garcia-Serra, R, Vara, M, Blanco, ML, Oiartzabal, I, Alvarez, S, Bernal, T, Granada, I, Xicoy, B, Jerez, A, Calabuig, M, Diez, R, Gil, A, Diez-Campelo, M, Solano, C, Tormo, M. Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. BRITISH JOURNAL OF HAEMATOLOGY. 2021; 194(4)DOI:10.1111/bjh.17675. PMID:34296432. IF:8.615(Q1/2D).